<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35918363</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>02</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Correlation of weight and body composition with disease progression rate in patients with amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>13292</StartPage><MedlinePgn>13292</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">13292</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-16229-9</ELocationID><Abstract><AbstractText>This study aims to observe the nutritional status of Chinese patients with amyotrophic lateral sclerosis (ALS), further investigating its effect on disease progression. One hundred consecutive newly diagnosed ALS patients and fifty controls were included. Weight and body composition were measured by bioelectrical impedance analysis at baseline and follow-ups. The revised ALS functional rating scale (ALSFRS-R) was used to calculate the rate of disease progression. Patients with ALS had a significantly lower BMI than controls, while no significant difference was found in body composition. Weight loss occurred in 66 (66%) and 52 (67.5%) patients at diagnosis and follow-up, respectively. Patients with significant weight loss (&#x2265;&#x2009;5%) at diagnosis had significantly lower BMI, fat mass (FM), and FM in limbs and trunk than those without. Fat-free mass (FFM), FM, and FM in limbs were significantly decreased along with weight loss at follow-up (p&#x2009;&lt;&#x2009;0.01). Patients with lower visceral fat index, lower proportion of FM, and higher proportion of muscle mass at baseline progressed rapidly during follow-ups (p&#x2009;&lt;&#x2009;0.05). Multivariate linear regression showed that FFM and weight at follow-up were independently correlated with disease progression rate at follow-up (p&#x2009;&lt;&#x2009;0.05). Weight loss is a common feature in ALS patients, along with muscle and fat wasting during the disease course. Body composition may serve as a prognostic factor and provide guidance for nutritional management in ALS patients.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jin-Yue</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Xiao-Han</ForeName><Initials>XH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Zheng-Yi</ForeName><Initials>ZY</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Dong-Chao</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xun-Zhe</ForeName><Initials>XZ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ming-Sheng</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Li-Ying</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, China. pumchcuily@yahoo.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Center, Chinese Academy of Medical Sciences, Beijing, 100730, China. pumchcuily@yahoo.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001823" MajorTopicYN="N">Body Composition</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015431" MajorTopicYN="N">Weight Loss</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>2</Day><Hour>23</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35918363</ArticleId><ArticleId IdType="pmc">PMC9345931</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-16229-9</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-16229-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gomez JJ, Ballesteros-Pomar MD, Torres-Torres B, De la Maza BP, Penacho-Lazaro MA, Palacio-Mures JM, Abreu-Padin C, Lopez-Guzman A, De Luis-Roman DA. Malnutrition at diagnosis in amyotrophic lateral sclerosis (als) and its influence on survival: Using glim criteria. Clin. Nutr. 2021;40:237&#x2013;244. doi: 10.1016/j.clnu.2020.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2020.05.014</ArticleId><ArticleId IdType="pubmed">32507583</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Desport JC, Kajeu P, Jesus P, Nicolaud B, Nicol M, Preux PM, Couratier P. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J. Neurol. Neurosurg. Psychiatry. 2011;82:628&#x2013;634. doi: 10.1136/jnnp.2010.211474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.211474</ArticleId><ArticleId IdType="pubmed">21097551</ArticleId></ArticleIdList></Reference><Reference><Citation>Moglia C, Calvo A, Grassano M, Canosa A, Manera U, D'Ovidio F, Bombaci A, Bersano E, Mazzini L, Mora G, Chio A, Piemonte A. Early weight loss in amyotrophic lateral sclerosis: Outcome relevance and clinical correlates in a population-based cohort. J. Neurol. Neurosurg. Psychiatry. 2019;90:666&#x2013;673. doi: 10.1136/jnnp-2018-319611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319611</ArticleId><ArticleId IdType="pubmed">30630957</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo ST, van Eijk RPA, Chachay V, van den Berg LH, McCombe PA, Henderson RD, Steyn FJ. Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 2019;20:497&#x2013;505. doi: 10.1080/21678421.2019.1621346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1621346</ArticleId><ArticleId IdType="pubmed">31144522</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarlarini C, Greco LC, Lizio A, Gerardi F, Sansone VA, Lunetta C. Taste changes in amyotrophic lateral sclerosis and effects on quality of life. Neurol. Sci. 2019;40:399&#x2013;404. doi: 10.1007/s10072-018-3672-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-018-3672-z</ArticleId><ArticleId IdType="pubmed">30515604</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayemendy P, Marin B, Labrunie A, Boirie Y, Walrand S, Achamrah N, Coeffier M, Preux PM, Lautrette G, Desport JC, Couratier P, Jesus P. Hypermetabolism is a reality in amyotrophic lateral sclerosis compared to healthy subjects. J. Neurol. Sci. 2021;420:117257. doi: 10.1016/j.jns.2020.117257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117257</ArticleId><ArticleId IdType="pubmed">33290920</ArticleId></ArticleIdList></Reference><Reference><Citation>Jesus P, Fayemendy P, Nicol M, Lautrette G, Sourisseau H, Preux PM, Desport JC, Marin B, Couratier P. Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis. Eur. J. Neurol. 2018;25:97&#x2013;104. doi: 10.1111/ene.13468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13468</ArticleId><ArticleId IdType="pubmed">28940704</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn FJ, Ioannides ZA, van Eijk RPA, Heggie S, Thorpe KA, Ceslis A, Heshmat S, Henders AK, Wray NR, van den Berg LH, Henderson RD, McCombe PA, Ngo ST. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J. Neurol. Neurosurg. Psychiatry. 2018;89:1016&#x2013;1023. doi: 10.1136/jnnp-2017-317887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317887</ArticleId><ArticleId IdType="pmc">PMC6166607</ArticleId><ArticleId IdType="pubmed">29706605</ArticleId></ArticleIdList></Reference><Reference><Citation>Chelstowska B, Kuzma-Kozakiewicz M. Biochemical parameters in determination of nutritional status in amyotrophic lateral sclerosis. Neurol. Sci. 2020;41:1115&#x2013;1124. doi: 10.1007/s10072-019-04201-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-04201-x</ArticleId><ArticleId IdType="pubmed">31897946</ArticleId></ArticleIdList></Reference><Reference><Citation>Nau KL, Bromberg MB, Forshew DA, Katch VL. Individuals with amyotrophic lateral sclerosis are in caloric balance despite losses in mass. J. Neurol. Sci. 1995;129(Suppl):47&#x2013;49. doi: 10.1016/0022-510x(95)00061-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510x(95)00061-6</ArticleId><ArticleId IdType="pubmed">7595619</ArticleId></ArticleIdList></Reference><Reference><Citation>Roubeau V, Blasco H, Maillot F, Corcia P, Praline J. Nutritional assessment of amyotrophic lateral sclerosis in routine practice: Value of weighing and bioelectrical impedance analysis. Muscle Nerve. 2015;51:479&#x2013;484. doi: 10.1002/mus.24419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24419</ArticleId><ArticleId IdType="pubmed">25130859</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindauer E, Dupuis L, Muller HP, Neumann H, Ludolph AC, Kassubek J. Adipose tissue distribution predicts survival in amyotrophic lateral sclerosis. PLoS ONE. 2013;8:e67783. doi: 10.1371/journal.pone.0067783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067783</ArticleId><ArticleId IdType="pmc">PMC3694869</ArticleId><ArticleId IdType="pubmed">23826340</ArticleId></ArticleIdList></Reference><Reference><Citation>Janse van Mantgem MR, van Eijk RPA, van der Burgh HK, Tan HHG, Westeneng HJ, van Es MA, Veldink JH, van den Berg LH. Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: A population-based study. J. Neurol. Neurosurg. Psychiatry. 2020;91:867&#x2013;875. doi: 10.1136/jnnp-2020-322909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-322909</ArticleId><ArticleId IdType="pubmed">32576612</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter RS, Rosenbohm A, Dupuis L, Brehme T, Kassubek J, Rothenbacher D, Nagel G, Ludolph AC. Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: Results from the ALS registry Swabia. Eur. J. Epidemiol. 2017;32:901&#x2013;908. doi: 10.1007/s10654-017-0318-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-017-0318-z</ArticleId><ArticleId IdType="pubmed">28975435</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Q, Ou R, Chen Y, Chen X, Cao B, Hou Y, Zhang L, Shang H. RNM-01 weight stability is associated with longer survival in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 2019;20:309&#x2013;326. doi: 10.1080/21678421.2019.1647001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1647001</ArticleId><ArticleId IdType="pubmed">31702466</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama Y, Shimizu T, Matsuda C, Haraguchi M, Hayashi K, Bokuda K, Nagao M, Kawata A, Ishikawa-Takata K, Isozaki E. Body weight variation predicts disease progression after invasive ventilation in amyotrophic lateral sclerosis. Sci. Rep. 2019;9:12262. doi: 10.1038/s41598-019-48831-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-48831-9</ArticleId><ArticleId IdType="pmc">PMC6706382</ArticleId><ArticleId IdType="pubmed">31439899</ArticleId></ArticleIdList></Reference><Reference><Citation>Schimmel M, Leuchter I, Heritier Barras AC, Leles CR, Abou-Ayash S, Viatte V, Esteve F, Janssens JP, Mueller F, Genton L. Oral function in amyotrophic lateral sclerosis patients: A matched case-control study. Clin. Nutr. 2021;40:4904&#x2013;4911. doi: 10.1016/j.clnu.2021.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2021.06.022</ArticleId><ArticleId IdType="pubmed">34358835</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaisman N, Lusaus M, Nefussy B, Niv E, Comaneshter D, Hallack R, Drory VE. Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs? J. Neurol. Sci. 2009;279:26&#x2013;29. doi: 10.1016/j.jns.2008.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2008.12.027</ArticleId><ArticleId IdType="pubmed">19185883</ArticleId></ArticleIdList></Reference><Reference><Citation>Barone M, Viggiani MT, Introna A, D'Errico E, Scarafino A, Iannone A, Di Leo A, Simone IL. Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement. Amyotroph. Lateral Scler. Frontotemporal Degener. 2019;20:490&#x2013;496. doi: 10.1080/21678421.2019.1643374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1643374</ArticleId><ArticleId IdType="pubmed">31347407</ArticleId></ArticleIdList></Reference><Reference><Citation>Germeys C, Vandoorne T, Bercier V, Van Den Bosch L. Existing and emerging metabolomic tools for ALS research. Genes (Basel) 2019 doi: 10.3390/genes10121011.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes10121011</ArticleId><ArticleId IdType="pmc">PMC6947647</ArticleId><ArticleId IdType="pubmed">31817338</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharaoh G, Sataranatarajan K, Street K, Hill S, Gregston J, Ahn B, Kinter C, Kinter M, Van Remmen H. Metabolic and stress response changes precede disease onset in the spinal cord of mutant SOD1 ALS mice. Front. Neurosci. 2019;13:487. doi: 10.3389/fnins.2019.00487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00487</ArticleId><ArticleId IdType="pmc">PMC6554287</ArticleId><ArticleId IdType="pubmed">31213966</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamiuc L, Schlagowski A, Ngo ST, Vernay A, Dirrig-Grosch S, Henriques A, Boutillier AL, Zoll J, Echaniz-Laguna A, Loeffler JP, Rene F. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol. Med. 2015;7:526&#x2013;546. doi: 10.15252/emmm.201404433.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201404433</ArticleId><ArticleId IdType="pmc">PMC4492815</ArticleId><ArticleId IdType="pubmed">25820275</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, Sui Y, Gao W, Cai B, Fan D. Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model. J. Int. Med. Res. 2015;43:67&#x2013;79. doi: 10.1177/0300060514554725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060514554725</ArticleId><ArticleId IdType="pubmed">25534414</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlan KS, Halang L, Woods I, Prehn JH. A high-fat jelly diet restores bioenergetic balance and extends lifespan in the presence of motor dysfunction and lumbar spinal cord motor neuron loss in TDP-43A315T mutant C57BL6/J mice. Dis. Model Mech. 2016;9:1029&#x2013;1037. doi: 10.1242/dmm.024786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.024786</ArticleId><ArticleId IdType="pmc">PMC5047697</ArticleId><ArticleId IdType="pubmed">27491077</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee I, Kazamel M, McPherson T, McAdam J, Bamman M, Amara A, Smith DL, Jr, King PH. Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study. PLoS ONE. 2021;16:e0251087. doi: 10.1371/journal.pone.0251087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0251087</ArticleId><ArticleId IdType="pmc">PMC8101939</ArticleId><ArticleId IdType="pubmed">33956876</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JW, Kim M, Baek SH, Sung JH, Yu JG, Kim BJ. Body fat percentage and availability of oral food intake: Prognostic factors and implications for nutrition in amyotrophic lateral sclerosis. Nutrients. 2021 doi: 10.3390/nu13113704.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13113704</ArticleId><ArticleId IdType="pmc">PMC8622757</ArticleId><ArticleId IdType="pubmed">34835960</ArticleId></ArticleIdList></Reference><Reference><Citation>Quessada C, Bouscary A, Rene F, Valle C, Ferri A, Ngo ST, Loeffler JP. Skeletal muscle metabolism: Origin or prognostic factor for amyotrophic lateral sclerosis (ALS) development? Cells. 2021 doi: 10.3390/cells10061449.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10061449</ArticleId><ArticleId IdType="pmc">PMC8226541</ArticleId><ArticleId IdType="pubmed">34207859</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaszkiewicz M, Willows JW, Dubois AL, Waible S, DiBello K, Lyons LL, Johnson CP, Paradie E, Banks N, Motyl K, Michael M, Harrison B, Townsend KL. Neuropathy and neural plasticity in the subcutaneous white adipose depot. PLoS ONE. 2019;14:e0221766. doi: 10.1371/journal.pone.0221766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0221766</ArticleId><ArticleId IdType="pmc">PMC6738614</ArticleId><ArticleId IdType="pubmed">31509546</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim MM. Subcutaneous and visceral adipose tissue: Structural and functional differences. Obes. Rev. 2010;11:11&#x2013;18. doi: 10.1111/j.1467-789X.2009.00623.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1467-789X.2009.00623.x</ArticleId><ArticleId IdType="pubmed">19656312</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel P, Abate N. Body fat distribution and insulin resistance. Nutrients. 2013;5:2019&#x2013;2027. doi: 10.3390/nu5062019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu5062019</ArticleId><ArticleId IdType="pmc">PMC3725490</ArticleId><ArticleId IdType="pubmed">23739143</ArticleId></ArticleIdList></Reference><Reference><Citation>Oka R, Yagi K, Sakurai M, Nakamura K, Nagasawa SY, Miyamoto S, Nohara A, Kawashiri MA, Hayashi K, Takeda Y, Yamagishi M. Impact of visceral adipose tissue and subcutaneous adipose tissue on insulin resistance in middle-aged Japanese. J. Atheroscler. Thromb. 2012;19:814&#x2013;822. doi: 10.5551/jat.12294.</Citation><ArticleIdList><ArticleId IdType="doi">10.5551/jat.12294</ArticleId><ArticleId IdType="pubmed">22813532</ArticleId></ArticleIdList></Reference><Reference><Citation>Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004;145:2273&#x2013;2282. doi: 10.1210/en.2003-1336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2003-1336</ArticleId><ArticleId IdType="pubmed">14726444</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishizu Y, Ishigami M, Honda T, Imai N, Ito T, Yamamoto K, Fujishiro M. Impact of visceral fat accumulation on the prognosis of patients with cirrhosis. Clin. Nutr. ESPEN. 2021;42:354&#x2013;360. doi: 10.1016/j.clnesp.2021.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2021.01.008</ArticleId><ArticleId IdType="pubmed">33745605</ArticleId></ArticleIdList></Reference><Reference><Citation>Boparai G, Kedia S, Kandasamy D, Sharma R, Madhusudhan KS, Dash NR, Sahu P, Pal S, Sahni P, Panwar R, Vuyyuru SK, Kante B, Yadav DP, Mouli VP, Makharia G, Ahuja V. Combination of sarcopenia and high visceral fat predict poor outcomes in patients with Crohn's disease. Eur. J. Clin. Nutr. 2021;75:1491&#x2013;1498. doi: 10.1038/s41430-021-00857-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41430-021-00857-x</ArticleId><ArticleId IdType="pubmed">33531636</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, Highton-Williamson E, Caga J, Thornton N, Ramsey E, Zoing M, Kim WS, Halliday GM, Piguet O, Hodges JR, Farooqi IS, Kiernan MC. Lipid metabolism and survival across the frontotemporal dementia-amyotrophic lateral sclerosis spectrum: Relationships to eating behavior and cognition. J. Alzheimers Dis. 2018;61:773&#x2013;783. doi: 10.3233/JAD-170660.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170660</ArticleId><ArticleId IdType="pubmed">29254092</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C, De Carvalho M, Genge A, Heiman-Patterson T, Shefner JM, Wei J, Wolff AA. Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-R. Amyotroph. Lateral Scler. Frontotemporal Degener. 2018;19:506&#x2013;512. doi: 10.1080/21678421.2018.1497658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1497658</ArticleId><ArticleId IdType="pubmed">30379086</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto S, de Carvalho M. The R of ALSFRS-R: does it really mirror functional respiratory involvement in amyotrophic lateral sclerosis? Amyotroph. Lateral Scler. Frontotemporal Degener. 2015;16:120&#x2013;123. doi: 10.3109/21678421.2014.952641.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.952641</ArticleId><ArticleId IdType="pubmed">25205208</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron. Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Rouleau GA, Ravits J, Cashman NR. Clinical spectrum of amyotrophic lateral sclerosis (ALS) Cold Spring Harb. Perspect. Med. 2017 doi: 10.1101/cshperspect.a024117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024117</ArticleId><ArticleId IdType="pmc">PMC5538408</ArticleId><ArticleId IdType="pubmed">28003278</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J, Appel S, Baloh RH, Barohn R, Brooks BR, Elman L, Floeter MK, Henderson C, Lomen-Hoerth C, Macklis JD, McCluskey L, Mitsumoto H, Przedborski S, Rothstein J, Trojanowski JQ, van den Berg LH, Ringel S. Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis. Amyotroph. Lateral Scler. Frontotemporal Degener. 2013;14(Suppl 1):5&#x2013;18. doi: 10.3109/21678421.2013.778548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.778548</ArticleId><ArticleId IdType="pmc">PMC3779649</ArticleId><ArticleId IdType="pubmed">23678876</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Q, Chen X, Zheng Z, Guo X, Huang R, Cao B, Zeng Y, Shang H. The predictors of survival in Chinese amyotrophic lateral sclerosis patients. Amyotroph. Lateral Scler. Frontotemporal Degener. 2015;16:237&#x2013;244. doi: 10.3109/21678421.2014.993650.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.993650</ArticleId><ArticleId IdType="pubmed">25581512</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu CH, Macdonald-Wallis C, Gray E, Pearce N, Petzold A, Norgren N, Giovannoni G, Fratta P, Sidle K, Fish M, Orrell R, Howard R, Talbot K, Greensmith L, Kuhle J, Turner MR, Malaspina A. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis. Neurology. 2015;84:2247&#x2013;2257. doi: 10.1212/WNL.0000000000001642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001642</ArticleId><ArticleId IdType="pmc">PMC4456658</ArticleId><ArticleId IdType="pubmed">25934855</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Jiang H, Yang JX, Yang H, Liu JM, Zhen XY, Feng LJ, Yu JC. Body composition analysis by using bioelectrical impedance in a young healthy Chinese population: Methodological considerations. Food Nutr. Bull. 2017;38:172&#x2013;181. doi: 10.1177/0379572117697534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0379572117697534</ArticleId><ArticleId IdType="pubmed">28513264</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoesmith C, Abrahao A, Benstead T, Chum M, Dupre N, Izenberg A, Johnston W, Kalra S, Leddin D, O'Connell C, Schellenberg K, Tandon A, Zinman L. Canadian best practice recommendations for the management of amyotrophic lateral sclerosis. CMAJ. 2020;192:E1453&#x2013;E1468. doi: 10.1503/cmaj.191721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.191721</ArticleId><ArticleId IdType="pmc">PMC7683000</ArticleId><ArticleId IdType="pubmed">33199452</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>